These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15587340)

  • 1. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A].
    Hamdani I; Kochlef A; Belhadj N; Kharrat J; Ghorbel A
    Tunis Med; 2008 Apr; 86(4):404-5. PubMed ID: 19476158
    [No Abstract]   [Full Text] [Related]  

  • 3. Pericarditis after therapy with interferon-alpha for chronic hepatitis C.
    Boonen A; Stockbrügger RW; van der Linden S
    Clin Rheumatol; 1999; 18(2):177-9. PubMed ID: 10357129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report.
    Popescu C; Arama V; Gliga S
    BMC Gastroenterol; 2011 Mar; 11():30. PubMed ID: 21453456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection.
    Shen Y; Pielop J; Hsu S
    Arch Dermatol; 2005 Jan; 141(1):102-3. PubMed ID: 15655158
    [No Abstract]   [Full Text] [Related]  

  • 7. Guess what! Tinea manus during interferon-alpha therapy for chronic hepatitis C.
    Koga T; Shimizu A; Kubota Y; Nakayama J; Sohda T
    Eur J Dermatol; 2000; 10(7):565-6. PubMed ID: 11056434
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C.
    Gabrielli M; Santarelli L; Serricchio M; Leo D; Pola P; Gasbarrini A
    Am J Gastroenterol; 2003 Apr; 98(4):940. PubMed ID: 12738487
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
    Tasi TN; Hsieh CH
    N Z Med J; 2004 Dec; 117(1207):U1230. PubMed ID: 15608817
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary sarcoidosis--a rare complication of interferon treatment for chronic hepatitis C].
    Pellová A; Pella J; Schréter I; Somos A; Kristian P; Boom A
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):200-2. PubMed ID: 17080355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pericarditis secondary to interferon alpha in chronic hepatitis C].
    Wisniewski B; Denis J; Fischer D; Labayle D
    Gastroenterol Clin Biol; 2004 Mar; 28(3):315-6. PubMed ID: 15094688
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
    McHutchison JG; Patel K; Schiff ER; Gitlin N; Mur RE; Everson GT; Carithers RL; Davis GL; Marcellin P; Shiffman ML; Harvey J; Albrecht JK;
    Aliment Pharmacol Ther; 2008 Mar; 27(5):422-32. PubMed ID: 18081733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy for chronic viral hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Kartal ED; Alpat SN; Ozgunes I; Usluer G
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Place of consensus type interferon alpha in the management of chronic type C hepatitis].
    Juszczyk J
    Pol Merkur Lekarski; 2003 Apr; 14(82):275-8. PubMed ID: 12868183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.